Axsome Therapeutics
AXSM
AXSM
49 hedge funds and large institutions have $30.2M invested in Axsome Therapeutics in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
27% less capital invested
Capital invested by funds: $41.6M → $30.2M (-$11.4M)
Holders
49
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.44M | |
| 2 | +$1.92M | |
| 3 | +$1.56M | |
| 4 |
NC
Nexthera Capital
New York
|
+$1.56M |
| 5 |
OPPM
Opus Point Partners Management
New York
|
+$1.04M |
Top Sellers
| 1 | -$2.2M | |
| 2 | -$1.69M | |
| 3 | -$127K | |
| 4 |
JPMorgan Chase & Co
New York
|
-$32.5K |
| 5 |
Bank of New York Mellon
New York
|
-$31.7K |